Dr. Ken Anderson highlights the bright future for multiple myeloma treatment Ken Anderson, MD highlights the great hope for multiple myeloma patients and their families based on the many new treatment options available and the research being done to better understand the disease and develop even more effective therapies. Learn more about the Jerome Lipper […]
Read More
Cancer Institute Announces Recruitment of Specialist Grade I, II and Staff Nurse at cnci.ac.in … Chittaranjan National Cancer Institute (CNCI), Kolkata has invited online applications for the recruitment of various posts under Specialist Grade I, Grade II and Staff Nurse at www.cnci.ac.in. Over 150 vacancies have been notified under this recruitment drive. CNCI is accepting […]
Read More
Merck Builds on Leadership in Head and Neck Cancer Through Worldwide Licensing Agreement … – Xevinapant is the first Inhibitor of Apoptosis Proteins antagonist with FDA Breakthrough Therapy Designation for previously untreated locally advanced squamous cell carcinoma of the head and neck, in combination with current standard of care – A Phase II trial reported […]
Read More
No hiding place for cancer European researchers have made a breakthrough paving the way for the development of precision treatments that can destroy cancers at source. Until now the similarity between cancer cells and healthy cells has made destroying one while protecting the other tough. But a new method developed by teams from the Centre […]
Read More
FY2021 EPS Estimates for Fate Therapeutics, Inc. (NASDAQ:FATE) Decreased by Cantor Fitzgerald Fate Therapeutics, Inc. (NASDAQ:FATE) – Stock analysts at Cantor Fitzgerald dropped their FY2021 earnings estimates for shares of Fate Therapeutics in a note issued to investors on Thursday, February 25th. Cantor Fitzgerald analyst A. Young now anticipates that the biopharmaceutical company will post […]
Read More
Liposomal Doxorubicin Volume Analysis, Segments, Value Share and Key Trends 2021-2030 Growth Prospects of the Global Liposomal Doxorubicin Market The comprehensive study on the Liposomal Doxorubicin market provides crucial insights to the stakeholders who are vying to solidify their presence in the current and future market landscape. The various factors that are likely to shape […]
Read More Q2 2021 EPS Estimates for Genmab A/S (NASDAQ:GMAB) Decreased by Truist Securiti Genmab A/S (NASDAQ:GMAB) – Stock analysts at Truist Securiti dropped their Q2 2021 earnings per share (EPS) estimates for Genmab A/S in a note issued to investors on Thursday, February 25th. Truist Securiti analyst A. Goonewardene now forecasts that the company will post […]
Read More
Cancer patients stranded by dispute between oncologists, Anne Arundel Medical Center Unfortunately, our website is currently unavailable in most European countries. We are engaged on the issue and committed to looking at options that support our full range of digital offerings to the EU market. We continue to identify technical compliance solutions that will provide […]
Read More
More than 2500 cancer diagnoses missed in Victoria during pandemic curbs While the true extent of the thousands of missed cancer diagnoses is not yet unknown, concerns are mounting that the delays in diagnoses will hinder the prospects of patients diagnosed with more aggressive cancers and could lead to avoidable deaths. Loading Professor Evans foreshadowed […]
Read More
AstraZeneca to Market Junshi Bio’s PD-1 Cancer Drug in China Bloomberg Bloomberg | Quint is a multiplatform, Indian business and financial news company. We combine Bloomberg’s global leadership in business and financial news and data, with Quintillion Media’s deep expertise in the Indian market and digital news delivery, to provide high quality business news, insights […]
Read More